作者投稿
专家审稿
编辑办公
邮件订阅
RSS
-
-
表 1 银屑病发病性别和年龄分布
作者 国家/地区 时间 诊断 患病率(%) M:F 高峰年龄(岁) Augustin等[33] 德国 2005 至少1名内科医生诊断，按
WHO-ICD-10(L40)标准2. 53 未研究 55 ~ 75 Nevitt等[34] 英国 疾病记录员 1. 48 无差异 平均33 Gelfand等[35] 英国 1987—2002 全科医生 1. 5 无差异 年轻人，＞70岁患病率下降 Ferrándiz等[36] 西班牙 1998 培训后的调查员(非医务人员) 1. 17 ~ 1. 43 无差异 20 ~ 50 Saraceno等[37] 意大利 2006 皮肤科医生设计的调查问卷 2. 9 未研究 未研究 全国银屑病流行调查组[17] 中国内地 1984 医务人员 0. 123 M＞F 男: 50 ~ 54;女: 30 ~ 34 丁晓岚等[21] 中国内地 2007—2008 皮肤科医生/培训后的调查员问卷 0. 47 无差异 初发年龄: 36. 23 ± 20. 26 Chang等[38] 中国台湾 2000—2006 皮肤科医生或风湿科医生 0. 19 M＞F ＞ 70岁 Tsai等[39] 中国台湾 2006 ICD-9-CM诊断标准696. 0-1 0. 235 M:F = 1. 6:1 46. 4 ± 18. 6 Siow等[22] 马来西亚 皮肤科医生 2. 15 M:F = 1. 7:1 平均43. 7，初发33. 1，
家族史阳性者初发29. 3M:男性; F:女性 
下载: 导出CSV
-
[1] Kim GK, Del Rosso JQ. Drug-provoked psoriasis:is it drug induced or drug aggravated?:understanding pathophysiology and clinical relevance[J]. J Clin Aesthet Dermatol, 2010, 3:32-38. http://europepmc.org/articles/PMC2921739 [2] Milavec-Puretic V. Drug induced psoriasis[J]. Acta Dermatovenerol Croat, 2011, 19:39-42. [3] Lionel F, Baker B. Triggering psoriasis:the role of infections and medications[J]. Clin Dermatol, 2007, 25:606-615. doi: 10.1016/j.clindermatol.2007.08.015 [4] Naldi L, Chatenoud L, Belloni A, et al. Medical history, drug exposure and the risk of psoriasis. Evidence from an Italian case-control study[J]. Dermatology, 2008, 216:125-130. doi: 10.1159/000111509 [5] Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women:Nurses' Health Study[J]. Arch Intern Med, 2007, 167:1670-1675. doi: 10.1001/archinte.167.15.1670 [6] Bryld LE, Sørensen TI, Andersen KK, et al. High body mass index in adolescent girls precedes psoriasis hospitalization[J]. Acta Derm Venereol, 2010, 90:488-493. doi: 10.2340/00015555-0931 [7] Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women:Nurses'Health Study Ⅱ[J]. Am J Med, 2007, 120:953-959. doi: 10.1016/j.amjmed.2007.06.020 [8] Li W, Han J, Choi HK, et al. Smoking and risk of incident psoriasis among women and men in the United States:a combined analysis[J]. Am J Epidemiol, 2012, 175:402-413. doi: 10.1093/aje/kwr325 [9] Fortes C, Mastroeni S, Leffondré K, et al. Relationship between smoking and the clinical severity of psoriasis[J]. Arch Dermatol, 2005, 41:1580-1584. http://www.tandfonline.com/servlet/linkout?suffix=CIT0024&dbid=16&doi=10.3109%2F09546634.2015.1107180&key=10.1001%2Farchderm.141.12.1580 [10] Naldi L, Mercuri SR. Smoking and psoriasis:from epidemiology to pathomechanisms[J]. J Invest Dermatol, 2009, 129:2741-2743. doi: 10.1038/jid.2009.315 [11] Qureshi AA, Dominguez PL, Choi HK, et al. Alcohol intake and risk of incident psoriasis in US women:A prospective study[J]. Arch Dermatol, 2010, 146:1364-1369. doi: 10.1001/archdermatol.2010.204 [12] Kazakevich N, Moody MN, Landau JM, et al. Alcohol and skin disorders:with a focus on psoriasis[J]. Skin Therapy Lett, 2011, 16:5-6. http://www.ncbi.nlm.nih.gov/pubmed/21611681 [13] Verhoeven EW, Kraaimaat FW, Jong EM, et al. Effect of daily stressors on psoriasis:a prospective study[J]. J Invest Dermatol, 2009, 129:2075-2077. doi: 10.1038/jid.2008.460 [14] Fortune DG, Richards HL, Kirby B, et al. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy[J]. Arch Dermatol, 2003, 139:752-756. http://www.ncbi.nlm.nih.gov/pubmed/12810506 [15] 张国威, 邵长庚, 王光超.中国银屑病的年发病率及年龄易患率[J].皮肤病与性病, 1990, 12:62-68. http://www.cqvip.com/QK/96893X/19901/332616.html [16] Jacobson CC, Kumar S, Kimball AB. Latitude and psoriasis prevalence[J]. J Am Acad Dermatol, 2011, 65:870-873. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=8e3fd643cae909f8d3adf2bd96ccde10 [17] 全国银屑病流行调查组.全国1984年银屑病流行调查报告[J].皮肤病与性病, 1989, 11:60-72. http://www.cnki.com.cn/Article/CJFDTotal-PFBX198901031.htm [18] 魏瑾, 刘梅, 曲乐, 等.辽宁地区531例寻常性银屑病患者临床流行病学调查[J].国际皮肤性病学杂志, 2011, 37:4-6. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=gwyx-pfxbx201101002 [19] Youn JI, Park BS, Park SB, et al. Characterization of early and late onset psoriasis in the Korean population[J]. J Dermatol, 1999, 26:647-652. doi: 10.1111/j.1346-8138.1999.tb02066.x [20] Fan X, Xiao FL, Yang S, et al. Childhood psoriasis:a study of 277 patients from China[J]. J Eur Acad Dermatol Venereol, 2007, 21:762-765. doi: 10.1111/j.1468-3083.2007.02014.x [21] 丁晓岚, 王婷琳, 沈佚葳, 等.中国六省市银屑病流行病学调查[J].中国皮肤性病学杂志, 2010, 24:598-601. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgpfxbxzz201007003 [22] Siow KY, Safdar NA, Chong KH, et al. A clinical appraisal of patients with psoriasis treated in Seremban General Hospital, Malaysia[J]. Med J Malaysia, 2004, 59:330-334. http://www.ncbi.nlm.nih.gov/pubmed/15727378 [23] Bren L. Psoriasis:more than cosmetic[J]. FDA Consumer, 2004, 38:10-16. http://europepmc.org/abstract/MED/15595142 [24] Icen M, Crowson CS, McEvoy MT, et al. Trends in incidence of adult-onset psoriasis over three decades:a population based study[J]. J Am Acad Dermatol, 2009, 60:394-401. doi: 10.1016/j.jaad.2008.10.062 [25] Huerta C, Rivero E, Rodriguez LA. Incidence and risk factors for psoriasis in the general population[J]. Arch Dermatol, 2007, 143:1559-1565. http://www.tandfonline.com/servlet/linkout?suffix=CIT0001&dbid=8&doi=10.1080%2F14712598.2018.1445223&key=18087008 [26] Wilson FC, Icen M, Crowson CS, et al. Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades:a population-based study[J]. J Rheumatol, 2009, 36:361-367. doi: 10.3899/jrheum.080691 [27] Mowad CM, Margolis DJ, Halpern AC, et al. Hormonal influences on women with psoriasis[J]. Cutis May, 1998, 61:257-260. http://www.ncbi.nlm.nih.gov/pubmed/9608337 [28] Bell LM, Sedlack R, Beard CM, et al. Incidence of psoriasis in Rochester, Minn, 1980-1983[J]. Arch Dermatol, 1991, 127:1184-1187. doi: 10.1001/archderm.1991.01680070084010 [29] Dogra S, Yadav S. Psoriasis in India:Prevalence and pattern[J]. Indian J Dermatol Venereol Leprol, 2010, 76:595-601. doi: 10.4103/0378-6323.72443 [30] Kundakci N, Türsen U, Babiker, et al. The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients[J]. Int J Dermatol, 2002, 41:220-224. doi: 10.1046/j.1365-4362.2002.01462.x [31] Jesic S, Hosovski E. Prevalence of psoriasis vulgaris in West Serbia[J]. Srp Arh Celok Lek, 1994, 122:61-64. http://www.ncbi.nlm.nih.gov/pubmed/17972809 [32] Grjibovski AM, Olsen AO, Magnus P, et al. Psoriasis in Norwegian twins:contribution of genetic and environmental effects[J]. J Eur Acad Dermatol Venereol, 2007, 21:1337-1343. doi: 10.1111/j.1468-3083.2007.02268.x [33] Augustin M, Reich K, Glaeske G, et al. Co-morbidity and age-related prevalence of psoriasis:Analysis of Health Insurance Data in Germany[J]. Acta Derm Venereol, 2010, 90:147-151. doi: 10.2340/00015555-0770 [34] Nevitt GJ, Hutchinson PE. Psoriasis in the community:prevalence, severity and patients' beliefs and attitudes towards the disease[J]. Br J Dermatol, 1996, 135:533-537. doi: 10.1046/j.1365-2133.1996.d01-1035.x [35] Gelfand JM, Weinstein R, Porter SB, et al. Prevalence and treatment of psoriasis in UK:a population-based study[J]. Arch Dermatol, 2005, 141:1537-1541. http://bmjopen.bmj.com/lookup/external-ref?access_num=10.1001/archderm.141.12.1537&link_type=DOI [36] Ferrándiz C, Bordas X, García-Patos V, et al. Prevalence of psoriasis in Spain (Epiderma Project:phase Ⅰ)[J]. J Eur Acad Dermatol Venereol, 2011, 15:20-23. doi: 10.1046/j.1468-3083.2001.00191.x [37] Saraceno R, Mannheimer R, Chimenti S. Regional distribution of psoriasis in Italy[J]. J Eur Acad Dermatol Venereol, 2008, 22:324-329. doi: 10.1111/j.1468-3083.2007.02423.x [38] Chang YT, Chen TJ, Liu PC, et al. Epidemiological study of psoriasis in the national health insurance database in Taiwan[J]. Acta Derm Venereol, 2009, 89:262-266. doi: 10.2340/00015555-0642 [39] Tsai TF, Wang TS, Hung ST, et al. Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan[J]. J Dermatol Sci, 2011, 63:40-46. doi: 10.1016/j.jdermsci.2011.03.002 -
点击查看大图
表(1)
计量
- 文章访问数: 145
- HTML全文浏览量: 26
- PDF下载量: 2
- 被引次数: 0
